Advertisement

Genetic Advance in Depressive Disorder

  • Chen ZhangEmail author
  • Han Rong
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 1180)

Abstract

Major depressive disorder (MDD) and bipolar disorder (BPD) are both chronic, severe mood disorder with high misdiagnosis rate, leading to substantial health and economic burdens to patients around the world. There is a high misdiagnosis rate of bipolar depression (BD) just based on symptomology in depressed patients whose previous manic or mixed episodes have not been well recognized. Therefore, it is important for psychiatrists to identify these two major psychiatric disorders. Recently, with the accumulation of clinical sample sizes and the advances of methodology and technology, certain progress in the genetics of major depression and bipolar disorder has been made. This article reviews the candidate genes for MDD and BD, genetic variation loci, chromosome structural variation, new technologies, and new methods.

Keywords

Major depression Genetic progress Bipolar depression 

Notes

Acknowledgements

Parts of the contents in this chapter were reused from the articles (Maturana et al. 2015; Zant et al. 2011) with permissions.

References

  1. Abdolmaleky HM, Zhou JR, Thiagalingam S (2015) An update on the epigenetics of psychotic diseases and autism. Epigenomics 7(3):427–449PubMedCrossRefPubMedCentralGoogle Scholar
  2. Adzic M et al (2016) Antidepressant action on mitochondrial dysfunction in psychiatric disorders. Drug Dev Res 77(7):400–406PubMedCrossRefPubMedCentralGoogle Scholar
  3. Amin N, Belonogova NM, Jovanova O et al (2017a) Nonsynonymous variation in NKPD1 increases depressive symptoms in european populations. Biol Psychiat 81(8):702–707PubMedCrossRefPubMedCentralGoogle Scholar
  4. Amin N, Jovanova O, Adams HH et al (2017b) Exome-sequencing in a large population-based study reveals a rare Asn396ser variant in the LIPG gene associated with depressive symptoms. Mol Psychiatry 22(4):537–543PubMedCrossRefPubMedCentralGoogle Scholar
  5. Amin N, De Vrij FMS, Baghdadi M et al (2018) A rare missense variant in RCL1 segregates with depression in extended families. Mol Psychiatry 23(5):1120–1126PubMedCrossRefPubMedCentralGoogle Scholar
  6. Anastasia A et al (2013) Val66Met polymorphism of BDNF alters prodomain structure to induce neuronal growth cone retraction. Nat Commun 4:2490PubMedPubMedCentralCrossRefGoogle Scholar
  7. Ancin I et al (2011) Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder. World J Biol Psychiatry 12(5):376–384PubMedCrossRefPubMedCentralGoogle Scholar
  8. Anderson IM, Haddad PM, Scott J (2012) Bipolar disorder. BMJ 345:e8508PubMedCrossRefPubMedCentralGoogle Scholar
  9. Andersen AM, Pietrzak RH, Kranzler HR et al (2017) Polygenic scores for major depressive disorder and risk of alcohol dependence. JAMA Psychiatry 74(11):1153–1160PubMedPubMedCentralCrossRefGoogle Scholar
  10. Andreazza AC et al (2010) Mitochondrial complex I activity and oxidative damage to mitochondrial proteins in the prefrontal cortex of patients with bipolar disorder. Arch Gen Psychiatry 67(4):360–368PubMedCrossRefGoogle Scholar
  11. Ashok AH et al (2017) The dopamine hypothesis of bipolar affective disorder: the state of the art and implications for treatment. Mol Psychiatry 22(5):666–679PubMedPubMedCentralCrossRefGoogle Scholar
  12. Avery DH et al (1999) Nocturnal sweating and temperature in depression. Acta Psychiatr Scand 100(4):295–301PubMedCrossRefGoogle Scholar
  13. Azadmarzabadi E, Haghighatfard A, Mohammadi A (2018) Low resilience to stress is associated with candidate gene expression alterations in the dopaminergic signalling pathway. Psychogeriatr: Off J Jpn Psychogeriatr Soc 18(3):190–201CrossRefGoogle Scholar
  14. Baghai TC et al (2003) No influence of a functional polymorphism within the serotonin transporter gene on partial sleep deprivation in major depression. World J Biol Psychiatry 4(3):111–114PubMedCrossRefGoogle Scholar
  15. Baglioni C et al (2011) Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 135(1–3):10–19PubMedCrossRefPubMedCentralGoogle Scholar
  16. Bao AM, Meynen G, Swaab DF (2008) The stress system in depression and neurodegeneration: focus on the human hypothalamus. Brain Res Rev 57(2):531–553PubMedCrossRefPubMedCentralGoogle Scholar
  17. Basheer R et al (2007) Sleep deprivation upregulates A1 adenosine receptors in the rat basal forebrain. NeuroReport 18(18):1895–1899PubMedCrossRefPubMedCentralGoogle Scholar
  18. Bellet MM et al (2011) Ketamine influences CLOCK:BMAL1 function leading to altered circadian gene expression. PLoS ONE 6(8):e23982PubMedPubMedCentralCrossRefGoogle Scholar
  19. Benedetti F et al (1999) Influence of a functional polymorphism within the promoter of the serotonin transporter gene on the effects of total sleep deprivation in bipolar depression. Am J Psychiatry 156(9):1450–1452PubMedPubMedCentralGoogle Scholar
  20. Berk M, Nierenberg AA (2015) Three paths to drug discovery in psychiatry. Am J Psychiatry 172(5):412–414PubMedCrossRefPubMedCentralGoogle Scholar
  21. Berman RM et al (2000) Antidepressant effects of ketamine in depressed patients. Biol Psychiatry 47(4):351–354PubMedCrossRefGoogle Scholar
  22. Bhat AH et al (2015) Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight. Biomed Pharmacother 74:101–110PubMedCrossRefGoogle Scholar
  23. Borrelli E et al (2008) Decoding the epigenetic language of neuronal plasticity. Neuron 60(6):961–974PubMedPubMedCentralCrossRefGoogle Scholar
  24. Bunney B, Bunney WE (2013) Mechanisms of rapid antidepressant effects of sleep deprivation therapy: clock genes and circadian rhythms. Biol Psychiat 73(12):1164–1171PubMedCrossRefGoogle Scholar
  25. Burokas A, Arboleya S, Moloney RD et al (2017) Targeting the microbiota-gut-brain axis: prebiotics have anxiolytic and antidepressant-like effects and reverse the impact of chronic stress in mice. Biol Psychiat 82(7):472–487PubMedCrossRefGoogle Scholar
  26. Bustamante AC, Aiello AE, Guffanti G et al (2018) Fkbp5 DNA methylation does not mediate the association between childhood maltreatment and depression symptom severity in the detroit neighborhood health study. J Psychiatr Res 96:39–48PubMedCrossRefGoogle Scholar
  27. Calabro M et al (2018) Neuroplasticity, neurotransmission and brain-related genes in major depression and bipolar disorder: focus on treatment outcomes in an asiatic sample. Adv Ther 35(10):1656–1670PubMedPubMedCentralCrossRefGoogle Scholar
  28. Callicott JH et al (2005) Variation in DISC1 affects hippocampal structure and function and increases risk for schizophrenia. Proc Natl Acad Sci U S A 102(24):8627–8632PubMedPubMedCentralCrossRefGoogle Scholar
  29. Cardoner N et al (2013) Val66Met BDNF genotypes in melancholic depression: effects on brain structure and treatment outcome. Depress Anxiety 30(3):225–233PubMedCrossRefPubMedCentralGoogle Scholar
  30. Carpenter WT Jr, Bunney WE Jr (1971) Adrenal cortical activity in depressive illness. Am J Psychiatry 128(1):31–40PubMedCrossRefPubMedCentralGoogle Scholar
  31. Carter CJ (2007) Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem Int 50(3):461–490PubMedCrossRefPubMedCentralGoogle Scholar
  32. Cataldo AM et al (2010) Abnormalities in mitochondrial structure in cells from patients with bipolar disorder. Am J Pathol 177(2):575–585PubMedPubMedCentralCrossRefGoogle Scholar
  33. Chang YH et al (2013) Genetic variants of the BDNF and DRD3 genes in bipolar disorder comorbid with anxiety disorder. J Affect Disord 151(3):967–972PubMedCrossRefPubMedCentralGoogle Scholar
  34. Cheah SY et al (2015) Dysbindin (DTNBP1) variants are associated with hallucinations in schizophrenia. Eur Psychiatry 30(4):486–491PubMedCrossRefPubMedCentralGoogle Scholar
  35. Chen H, Huffman JE, Brody JA et al (2018) Efficient variant set mixed model association tests for continuous and binary traits in large-scale whole-genome sequencing studies. Am J Hum Genet 104(2):260–274Google Scholar
  36. Chesney E, Goodwin GM, Fazel S (2014) Risks of all-cause and suicide mortality in mental disorders: a meta-review. World Psychiatry: Off J World Psychiatr Assoc (WPA) 13(2):153–160CrossRefGoogle Scholar
  37. Cikankova T et al (2017) Mitochondrial dysfunctions in bipolar disorder: effect of the disease and pharmacotherapy. CNS Neurol Disord: Drug Targets 16(2):176–186CrossRefGoogle Scholar
  38. Clay HB, Sillivan S, Konradi C (2011) Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int J Dev Neurosci 29(3):311–324PubMedCrossRefPubMedCentralGoogle Scholar
  39. Craddock N, O’Donovan MC, Owen MJ (2005) The genetics of schizophrenia and bipolar disorder: dissecting psychosis. J Med Genet 42(3):193–204PubMedPubMedCentralCrossRefGoogle Scholar
  40. de Sousa RT et al (2014) Targeting mitochondrially mediated plasticity to develop improved therapeutics for bipolar disorder. Expert Opin Ther Targets 18(10):1131–1147PubMedPubMedCentralCrossRefGoogle Scholar
  41. Detera-Wadleigh SD, McMahon FJ (2006) G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60(2):106–114PubMedCrossRefPubMedCentralGoogle Scholar
  42. Dong Z et al (2016) Association of DISC1, BDNF, and COMT polymorphisms with exploratory eye movement of schizophrenia in a Chinese Han population. Psychiatr Genet 26(6):258–265PubMedCrossRefPubMedCentralGoogle Scholar
  43. Duff BJ et al (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 147(1):1–13PubMedCrossRefPubMedCentralGoogle Scholar
  44. Duncan WC Jr et al (1980) Relationship between EEG sleep patterns and clinical improvement in depressed patients treated with sleep deprivation. Biol Psychiatry 15(6):879–889PubMedPubMedCentralGoogle Scholar
  45. Duong A et al (2016) Regulators of mitochondrial complex I activity: a review of literature and evaluation in postmortem prefrontal cortex from patients with bipolar disorder. Psychiatry Res 236:148–157PubMedCrossRefPubMedCentralGoogle Scholar
  46. Elsenga S, Van den Hoofdakker RH (1988) Body core temperature and depression during total sleep deprivation in depressives. Biol Psychiatry 24(5):531–540PubMedCrossRefPubMedCentralGoogle Scholar
  47. Fallin MD et al (2005) Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6):918–936PubMedPubMedCentralCrossRefGoogle Scholar
  48. Fang X, Zhang C, Wu Z et al (2018) Prevalence, risk factors and clinical characteristics of suicidal ideation in Chinese patients with depression. J Affect Disord 235:135–141PubMedCrossRefPubMedCentralGoogle Scholar
  49. Fischer S, Gardini ES, Haas F et al (2018) Polymorphisms in genes related to the hypothalamic-pituitary-adrenal axis and antidepressant response—systematic review. Neurosci Biobehav Rev 96:182–196CrossRefGoogle Scholar
  50. Foo JC, Streit F, Treutlein J et al (2018) Shared genetic etiology between alcohol dependence and major depressive disorder. Psychiatr Genet 28(4):66–70PubMedPubMedCentralCrossRefGoogle Scholar
  51. Fries GR et al (2016) The role of DNA methylation in the pathophysiology and treatment of bipolar disorder. Neurosci Biobehav Rev 68:474–488PubMedPubMedCentralCrossRefGoogle Scholar
  52. Fries GR, Carvalho AF, Quevedo J (2018) The miRNome of bipolar disorder. J Affect Disord 233:110–116PubMedCrossRefPubMedCentralGoogle Scholar
  53. Fukuda S et al (2010) A functional polymorphism in the disrupted-in schizophrenia 1 gene is associated with chronic fatigue syndrome. Life Sci 86(19–20):722–725PubMedCrossRefPubMedCentralGoogle Scholar
  54. Gillentine MA, Lozoya R, Yin J et al (2018) CHRNA7 copy number gains are enriched in adolescents with major depressive and anxiety disorders. J Affect Disord 239:247–252PubMedPubMedCentralCrossRefGoogle Scholar
  55. Goh S et al (2014) Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging. JAMA Psychiatry 71(6):665–671PubMedPubMedCentralCrossRefGoogle Scholar
  56. Goud Alladi C et al (2018) DNA methylation as a biomarker of treatment response variability in serious mental illnesses: a systematic review focused on bipolar disorder, schizophrenia, and major depressive disorder. Int J Mol Sci 19(10)PubMedCentralCrossRefGoogle Scholar
  57. Gray MW (2017) Lynn Margulis and the endosymbiont hypothesis: 50 years later. Mol Biol Cell 28(10):1285–1287PubMedPubMedCentralCrossRefGoogle Scholar
  58. Gupta R, Lahan V (2011) Insomnia associated with depressive disorder: primary, secondary, or mixed? Indian J Psychol Med 33(2):123–128PubMedPubMedCentralCrossRefGoogle Scholar
  59. Hall LS, Adams MJ, Arnau-Soler A et al (2018) Genome-wide meta-analyses of stratified depression in generation scotland and UK biobank. Transl Psychiatry 8(1):9PubMedPubMedCentralCrossRefGoogle Scholar
  60. Hashimoto R et al (2006) Impact of the DISC1 Ser704Cys polymorphism on risk for major depression, brain morphology and ERK signaling. Hum Mol Genet 15(20):3024–3033PubMedCrossRefPubMedCentralGoogle Scholar
  61. Hashimoto R et al (2015) Imaging genetics and psychiatric disorders. Curr Mol Med 15(2):168–175PubMedPubMedCentralCrossRefGoogle Scholar
  62. Hasler BP et al (2010) Phase relationships between core body temperature, melatonin, and sleep are associated with depression severity: further evidence for circadian misalignment in non-seasonal depression. Psychiatry Res 178(1):205–207PubMedPubMedCentralCrossRefGoogle Scholar
  63. Haug HJ (1992) Prediction of sleep deprivation outcome by diurnal variation of mood. Biol Psychiatry 31(3):271–278PubMedCrossRefPubMedCentralGoogle Scholar
  64. Havelka Mestrovic A et al (2018) Significant association between catechol-O-methyltransferase (COMT) Val(158/108) Met polymorphism and cognitive function in veterans with PTSD. Neurosci Lett 666:38–43PubMedCrossRefPubMedCentralGoogle Scholar
  65. Hek K, Demirkan A, Lahti J et al (2013) A genome-wide association study of depressive symptoms. Biol Psychiat 73(7):667–678PubMedCrossRefPubMedCentralGoogle Scholar
  66. Herrero-Mendez A et al (2009) The bioenergetic and antioxidant status of neurons is controlled by continuous degradation of a key glycolytic enzyme by APC/C-Cdh1. Nat Cell Biol 11(6):747–752PubMedCrossRefPubMedCentralGoogle Scholar
  67. Howard DM, Adams MJ, Shirali M et al (2018) Genome-wide association study of depression phenotypes in UK biobank identifies variants in excitatory synaptic pathways. Nat Commun 9(1):1470PubMedPubMedCentralCrossRefGoogle Scholar
  68. Hroudova J, Fisar Z (2011) Connectivity between mitochondrial functions and psychiatric disorders. Psychiatry Clin Neurosci 65(2):130–141PubMedCrossRefPubMedCentralGoogle Scholar
  69. Hu MC et al (2013) Association study of DRD2 and MAOA genes with subtyped alcoholism comorbid with bipolar disorder in Han Chinese. Prog Neuropsychopharmacol Biol Psychiatry 40:144–148PubMedCrossRefPubMedCentralGoogle Scholar
  70. Ikeda M, Saito T, Kondo K et al (2018) Genome-wide association studies of bipolar disorder: a systematic review of recent findings and their clinical implications. Psychiatry Clin Neurosci 72(2):52–63PubMedCrossRefPubMedCentralGoogle Scholar
  71. Iwamoto K, Bundo M, Kato T (2005) Altered expression of mitochondria-related genes in postmortem brains of patients with bipolar disorder or schizophrenia, as revealed by large-scale DNA microarray analysis. Hum Mol Genet 14(2):241–253PubMedCrossRefPubMedCentralGoogle Scholar
  72. Jiang Y et al (2008) Epigenetics in the nervous system. J Neurosci 28(46):11753–11759PubMedPubMedCentralCrossRefGoogle Scholar
  73. Jiang X et al (2009) Human BDNF isoforms are differentially expressed in cocaine addicts and are sorted to the regulated secretory pathway independent of the Met66 substitution. Neuromolecular Med 11(1):1–12PubMedCrossRefPubMedCentralGoogle Scholar
  74. Joo EJ et al (2007) Dysbindin gene variants are associated with bipolar I disorder in a Korean population. Neurosci Lett 418(3):272–275PubMedCrossRefPubMedCentralGoogle Scholar
  75. Kaalund SS et al (2014) Contrasting changes in DRD1 and DRD2 splice variant expression in schizophrenia and affective disorders, and associations with SNPs in postmortem brain. Mol Psychiatry 19(12):1258–1266PubMedCrossRefPubMedCentralGoogle Scholar
  76. Kailainathan S et al (2016) Activation of a synapse weakening pathway by human Val66 but not Met66 pro-brain-derived neurotrophic factor (proBDNF). Pharmacol Res 104:97–107PubMedPubMedCentralCrossRefGoogle Scholar
  77. Kandaswamy R et al (2013) Genetic association, mutation screening, and functional analysis of a Kozak sequence variant in the metabotropic glutamate receptor 3 gene in bipolar disorder. JAMA Psychiatry 70(6):591–598PubMedCrossRefPubMedCentralGoogle Scholar
  78. Kang Y et al (2015) Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser. Nature 523(7562):561–567PubMedPubMedCentralCrossRefGoogle Scholar
  79. Karsli-Ceppioglu S (2016) Epigenetic mechanisms in psychiatric diseases and epigenetic therapy. Drug Dev Res 77(7):407–413PubMedCrossRefPubMedCentralGoogle Scholar
  80. Kato T, Kato N (2000) Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2(3 Pt 1):180–190PubMedCrossRefPubMedCentralGoogle Scholar
  81. Kim HK, Chen W, Andreazza AC (2015) The potential role of the NLRP3 Inflammasome as a link between mitochondrial complex I dysfunction and inflammation in bipolar disorder. Neural Plast 2015:408136PubMedPubMedCentralGoogle Scholar
  82. Kirenskaya AV et al (2018) COMT and GAD1 gene polymorphisms are associated with impaired antisaccade task performance in schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 268(6):571–584PubMedPubMedCentralCrossRefGoogle Scholar
  83. Kishimoto M et al (2008) The dysbindin gene (DTNBP1) is associated with methamphetamine psychosis. Biol Psychiatry 63(2):191–196PubMedCrossRefPubMedCentralGoogle Scholar
  84. Krakow B et al (2011) Sleep disturbances and suicidal ideation in sleep medical center patients. J Affect Disord 131(1–3):422–427PubMedCrossRefPubMedCentralGoogle Scholar
  85. Labaka A, Gomez-Lazaro E, Vegas O et al (2017) Reduced hippocampal IL-10 expression, altered monoaminergic activity and anxiety and depressive-like behavior in female mice subjected to chronic social instability stress. Behav Brain Res 335:8–18PubMedCrossRefPubMedCentralGoogle Scholar
  86. Lelli-Chiesa G et al (2011) The impact of the Val158Met catechol-O-methyltransferase genotype on neural correlates of sad facial affect processing in patients with bipolar disorder and their relatives. Psychol Med 41(4):779–788PubMedCrossRefPubMedCentralGoogle Scholar
  87. Leon M, Morelis R, Louisot P (1983) Demonstration of a double subcellular localization of cerebral fucosyltransferase. Arch Int Physiol Biochim 91(2):121–125PubMedPubMedCentralGoogle Scholar
  88. Levinson DF, Mostafavi S, Milaneschi Y et al (2014) Genetic studies of major depressive disorder: why are there no genome-wide association study findings and what can we do about it? Biol Psychiat 76(7):510–512PubMedCrossRefPubMedCentralGoogle Scholar
  89. Li M, Chang H, Xiao X (2016) BDNF Val66Met polymorphism and bipolar disorder in European populations: a risk association in case-control, family-based and GWAS studies. Neurosci Biobehav Rev 68:218–233PubMedCrossRefGoogle Scholar
  90. Li X, Luo Z, Gu C et al (2018) Common variants on 6q16.2, 12q24.31 and 16p13.3 are associated with major depressive disorder. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 43(10):2146–2153Google Scholar
  91. Liu RT (2010) Early life stressors and genetic influences on the development of bipolar disorder: the roles of childhood abuse and brain-derived neurotrophic factor. Child Abuse Negl 34(7):516–522PubMedCrossRefGoogle Scholar
  92. Liu B et al (2015) DISC1 Ser704Cys impacts thalamic-prefrontal connectivity. Brain Struct Funct 220(1):91–100PubMedCrossRefGoogle Scholar
  93. Lo R, Weksberg R (2014) Biological and biochemical modulation of DNA methylation. Epigenomics 6(6):593–602PubMedCrossRefGoogle Scholar
  94. Lopez Leon S et al (2005) The dopamine D4 receptor gene 48-base-pair-repeat polymorphism and mood disorders: a meta-analysis. Biol Psychiatry 57(9):999–1003PubMedCrossRefGoogle Scholar
  95. Machado AK et al (2016) Upstream pathways controlling mitochondrial function in major psychosis: a focus on bipolar disorder. Can J Psychiatry 61(8):446–456PubMedPubMedCentralCrossRefGoogle Scholar
  96. Malhi GS et al (2015) Agitation for recognition by DSM-5 mixed features specifier signals fatigue? Aust NZ J Psychiatry 49(6):499–501CrossRefGoogle Scholar
  97. Manber R et al (2008) Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 31(4):489–495PubMedPubMedCentralCrossRefGoogle Scholar
  98. Marrocco J, Einhorn NR, Petty GH et al (2018) Epigenetic intersection of BDNF Val66Met genotype with premenstrual dysphoric disorder transcriptome in a cross-species model of estradiol add-back. Mol Psychiatry. https://doi.org/10.1038/s41380-018-0274-3
  99. Martin J, Tammimies K, Karlsson R et al (2018) Copy number variation and neuropsychiatric problems in females and males in the general population. Am J Med Genet B Neuropsychiatr Genet 180(6):341–350CrossRefGoogle Scholar
  100. Martiny K et al (2018) Psychiatry and circadian rhythms. Ugeskr Laeger 180(36)Google Scholar
  101. Massat I et al (2002) Excess of allele1 for alpha3 subunit GABA receptor gene (GABRA3) in bipolar patients: a multicentric association study. Mol Psychiatry 7(2):201–207PubMedCrossRefPubMedCentralGoogle Scholar
  102. Mattson MP, Gleichmann M, Cheng A (2008) Mitochondria in neuroplasticity and neurological disorders. Neuron 60(5):748–766PubMedPubMedCentralCrossRefGoogle Scholar
  103. Maturana MJ et al (2015) REM sleep deprivation reverses neurochemical and other depressive-like alterations induced by olfactory bulbectomy. Mol Neurobiol 51(1):349–360PubMedCrossRefGoogle Scholar
  104. McCarthy MJ et al (2012) A survey of genomic studies supports association of circadian clock genes with bipolar disorder spectrum illnesses and lithium response. PLoS ONE 7(2):e32091PubMedPubMedCentralCrossRefGoogle Scholar
  105. Mendlewicz J (2009) Sleep disturbances: core symptoms of major depressive disorder rather than associated or comorbid disorders. World J Biol Psychiatry 10(4):269–275PubMedCrossRefPubMedCentralGoogle Scholar
  106. Millan MJ (2013) An epigenetic framework for neurodevelopmental disorders: from pathogenesis to potential therapy. Neuropharmacology 68:2–82PubMedCrossRefPubMedCentralGoogle Scholar
  107. Montag C et al (2010) The BDNF Val66Met polymorphism and anxiety: support for animal knock-in studies from a genetic association study in humans. Psychiatry Res 179(1):86–90PubMedCrossRefPubMedCentralGoogle Scholar
  108. Morris G, Berk M (2015) The many roads to mitochondrial dysfunction in neuroimmune and neuropsychiatric disorders. BMC Med 13:68PubMedPubMedCentralCrossRefGoogle Scholar
  109. Morris G et al (2017) A model of the mitochondrial basis of bipolar disorder. Neurosci Biobehav Rev 74(Pt A):1–20PubMedCrossRefPubMedCentralGoogle Scholar
  110. Mundo E et al (2003) Evidence that the N-methyl-D-aspartate subunit 1 receptor gene (GRIN1) confers susceptibility to bipolar disorder. Mol Psychiatry 8(2):241–245PubMedCrossRefPubMedCentralGoogle Scholar
  111. Nemeroff CB (1996) The corticotropin-releasing factor (CRF) hypothesis of depression: new findings and new directions. Mol Psychiatry 1(4):336–342PubMedPubMedCentralGoogle Scholar
  112. Nishino J, Ochi H, Kochi Y et al (2018) Sample size for successful genome-wide association study of major depressive disorder. Front Genet 9:227PubMedPubMedCentralCrossRefGoogle Scholar
  113. Norkett R et al (2016) DISC1-dependent regulation of mitochondrial dynamics controls the morphogenesis of complex neuronal dendrites. J Biol Chem 291(2):613–629PubMedCrossRefPubMedCentralGoogle Scholar
  114. O’Brien EM et al (2011) Severe insomnia is associated with more severe presentation and greater functional deficits in depression. J Psychiatr Res 45(8):1101–1105PubMedCrossRefPubMedCentralGoogle Scholar
  115. O’connell CP, Goldstein-Piekarski AN, Nemeroff CB et al (2018) Antidepressant outcomes predicted by genetic variation in corticotropin-releasing hormone binding protein. Am J Psychiatry 175(3):251–261PubMedCrossRefPubMedCentralGoogle Scholar
  116. Okbay A, Baselmans BM, De Neve JE et al (2016) Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. Nat Genet 48(6):624–633PubMedPubMedCentralCrossRefGoogle Scholar
  117. Orru G, Carta MG (2018) Genetic variants involved in bipolar disorder, a rough road ahead. Clin Pract Epidemiol Ment Health 14:37–45PubMedPubMedCentralCrossRefGoogle Scholar
  118. Ostergaard SD, Jensen SO, Bech P (2011) The heterogeneity of the depressive syndrome: when numbers get serious. Acta Psychiatr Scand 124(6):495–496PubMedCrossRefPubMedCentralGoogle Scholar
  119. Ottenhof KW et al (2018) TPH2 polymorphisms across the spectrum of psychiatric morbidity: a systematic review and meta-analysis. Neurosci Biobehav Rev 92:29–42PubMedCrossRefPubMedCentralGoogle Scholar
  120. Paraskevaidi M et al (2017) Underlying role of mitochondrial mutagenesis in the pathogenesis of a disease and current approaches for translational research. Mutagenesis 32(3):335–342PubMedPubMedCentralGoogle Scholar
  121. Peedicayil J (2011) Epigenetic management of major psychosis. Clin Epigenetics 2(2):249–256PubMedPubMedCentralCrossRefGoogle Scholar
  122. Peterson RE, Cai N, Bigdeli TB et al (2017) The genetic architecture of major depressive disorder in han chinese women. JAMA Psychiatry 74(2):162–168PubMedPubMedCentralCrossRefGoogle Scholar
  123. Pflug B, Tolle R (1971) Disturbance of the 24-hour rhythm in endogenous depression and the treatment of endogenous depression by sleep deprivation. Int Pharmacopsychiatry 6(3):187–196PubMedCrossRefPubMedCentralGoogle Scholar
  124. Pirooznia M, Wang T, Avramopoulos D et al (2016) High-throughput sequencing of the synaptome in major depressive disorder. Mol Psychiatry 21(5):650–655PubMedCrossRefPubMedCentralGoogle Scholar
  125. Poletti S et al (2017) Brain-derived Neurotrophic Factor (BDNF) and gray matter volume in bipolar disorder. Eur Psychiatry 40:33–37PubMedCrossRefPubMedCentralGoogle Scholar
  126. Power RA, Tansey KE, Buttenschon HN et al (2017) Genome-wide association for major depression through age at onset stratification: Major depressive disorder working group of the psychiatric genomics consortium. Biol Psychiat 81(4):325–335PubMedCrossRefPubMedCentralGoogle Scholar
  127. Ratta-Apha W et al (2013) Association analysis of the DISC1 gene with schizophrenia in the Japanese population and DISC1 immunoreactivity in the postmortem brain. Neurosci Res 77(4):222–227PubMedCrossRefPubMedCentralGoogle Scholar
  128. Raybould R et al (2005) Bipolar disorder and polymorphisms in the dysbindin gene (DTNBP1). Biol Psychiatry 57(7):696–701PubMedCrossRefPubMedCentralGoogle Scholar
  129. Raznahan A et al (2011) Catechol-o-methyl transferase (COMT) val158met polymorphism and adolescent cortical development in patients with childhood-onset schizophrenia, their non-psychotic siblings, and healthy controls. Neuroimage 57(4):1517–1523PubMedPubMedCentralCrossRefGoogle Scholar
  130. Reddington JP, Pennings S, Meehan RR (2013) Non-canonical functions of the DNA methylome in gene regulation. Biochem J 451(1):13–23PubMedCrossRefPubMedCentralGoogle Scholar
  131. Reichenberg A, Mill J, MacCabe JH (2009) Epigenetics, genomic mutations and cognitive function. Cogn Neuropsychiatry 14(4–5):377–390PubMedCrossRefPubMedCentralGoogle Scholar
  132. Reif A et al (2014) MAOA and mechanisms of panic disorder revisited: from bench to molecular psychotherapy. Mol Psychiatry 19(1):122–128PubMedCrossRefPubMedCentralGoogle Scholar
  133. Ressler KJ, Nemeroff CB (2000) Role of serotonergic and noradrenergic systems in the pathophysiology of depression and anxiety disorders. Depress Anxiety 12(Suppl 1):2–19PubMedCrossRefPubMedCentralGoogle Scholar
  134. Rice F, Riglin L, Thapar AK et al (2019) Characterizing developmental trajectories and the role of neuropsychiatric genetic risk variants in early-onset depression. JAMA Psychiatry 76(3):306–313PubMedCrossRefPubMedCentralGoogle Scholar
  135. Richter-Schmidinger T et al (2011) Influence of brain-derived neurotrophic-factor and apolipoprotein E genetic variants on hippocampal volume and memory performance in healthy young adults. J Neural Transm (Vienna) 118(2):249–257CrossRefGoogle Scholar
  136. Riemann D, Wiegand M, Berger M (1991) Are there predictors for sleep deprivation response in depressed patients? Biol Psychiatry 29(7):707–710PubMedCrossRefPubMedCentralGoogle Scholar
  137. Ripke S, Wray NR, Lewis CM et al (2013) A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry 18(4):497–511PubMedCrossRefPubMedCentralGoogle Scholar
  138. Robillard R et al (2018) Circadian rhythms and psychiatric profiles in young adults with unipolar depressive disorders. Transl Psychiatry 8(1):213PubMedPubMedCentralCrossRefGoogle Scholar
  139. Rybakowski JK et al (2009) Dopamine D1 receptor gene polymorphism is associated with prophylactic lithium response in bipolar disorder. Pharmacopsychiatry 42(1):20–22PubMedCrossRefPubMedCentralGoogle Scholar
  140. Scharnholz B et al (2010) Does night-time cortisol excretion normalize in the long-term course of depression? Pharmacopsychiatry 43(5):161–165PubMedCrossRefPubMedCentralGoogle Scholar
  141. Schizophrenia Working Group of the Psychiatric Genomics Consortium (2014) Biological insights from 108 schizophrenia-associated genetic loci. Nature 511(7510):421–427Google Scholar
  142. Schubeler D (2015) Function and information content of DNA methylation. Nature 517(7534):321–326PubMedCrossRefPubMedCentralGoogle Scholar
  143. Scola G et al (2013) A fresh look at complex I in microarray data: clues to understanding disease-specific mitochondrial alterations in bipolar disorder. Biol Psychiatry 73(2):e4–e5PubMedCrossRefPubMedCentralGoogle Scholar
  144. Smith K (2014) Mental health: a world of depression. Nature 515(7526):181PubMedCrossRefPubMedCentralGoogle Scholar
  145. Soria V et al (2010) Differential association of circadian genes with mood disorders: CRY1 and NPAS2 are associated with unipolar major depression and CLOCK and VIP with bipolar disorder. Neuropsychopharmacology 35(6):1279–1289PubMedPubMedCentralCrossRefGoogle Scholar
  146. Sorrentino V, Menzies KJ, Auwerx J (2018) Repairing mitochondrial dysfunction in disease. Annu Rev Pharmacol Toxicol 58:353–389PubMedCrossRefPubMedCentralGoogle Scholar
  147. Souetre E et al (1988) Twenty-four-hour profiles of body temperature and plasma TSH in bipolar patients during depression and during remission and in normal control subjects. Am J Psychiatry 145(9):1133–1137PubMedCrossRefPubMedCentralGoogle Scholar
  148. Srivastava R et al (2018) Dynamic changes of the mitochondria in psychiatric illnesses: new mechanistic insights from human neuronal models. Biol Psychiatry 83(9):751–760PubMedPubMedCentralCrossRefGoogle Scholar
  149. Sullivan PF, Neale MC, Kendler KS (2000) Genetic epidemiology of major depression: review and meta-analysis. Am J Psychiatry 157(10):1552–1562CrossRefGoogle Scholar
  150. Szczepankiewicz A (2013) Evidence for single nucleotide polymorphisms and their association with bipolar disorder. Neuropsychiatr Dis Treat 9:1573–1582PubMedPubMedCentralCrossRefGoogle Scholar
  151. Szyf M (2015) Prospects for the development of epigenetic drugs for CNS conditions. Nat Rev Drug Discov 14(7):461–474PubMedCrossRefPubMedCentralGoogle Scholar
  152. Takaesu Y (2018) Circadian rhythm in bipolar disorder: a review of the literature. Psychiatry Clin Neurosci 72(9):673–682PubMedCrossRefPubMedCentralGoogle Scholar
  153. Taylor S (2018) Association between COMT Val158Met and psychiatric disorders: a comprehensive meta-analysis. Am J Med Genet B Neuropsychiatr Genet 177(2):199–210PubMedCrossRefPubMedCentralGoogle Scholar
  154. Teh CA et al (2012) Bipolar disorder, brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and brain morphology. PLoS ONE 7(7):e38469PubMedPubMedCentralCrossRefGoogle Scholar
  155. Tripp A et al (2012) Brain-derived neurotrophic factor signaling and subgenual anterior cingulate cortex dysfunction in major depressive disorder. Am J Psychiatry 169(11):1194–1202PubMedPubMedCentralCrossRefGoogle Scholar
  156. Trost S et al (2013) The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans. Eur Arch Psychiatry Clin Neurosci 263(1):53–63PubMedCrossRefPubMedCentralGoogle Scholar
  157. Uguz AC, Demirci K, Espino J (2016) The importance of melatonin and mitochondria interaction in mood disorders and schizophrenia: a current assessment. Curr Med Chem 23(20):2146–2158PubMedCrossRefPubMedCentralGoogle Scholar
  158. Van Der Auwera S, Peyrot WJ, Milaneschi Y et al (2018) Genome-wide gene-environment interaction in depression: a systematic evaluation of candidate genes: the childhood trauma working-group of PGC-MDD. Am J Med Genet Part B, Neuropsychiatr Genet: Off Publ Int Soc Psychiatr Genet 177(1):40–49CrossRefGoogle Scholar
  159. Wehr TA (2018) Bipolar mood cycles associated with lunar entrainment of a circadian rhythm. Transl Psychiatry 8(1):151PubMedPubMedCentralCrossRefGoogle Scholar
  160. Wong ML, Arcos-Burgos M, Liu S et al (2017) The PHF21B gene is associated with major depression and modulates the stress response. Mol Psychiatry 22(7):1015–1025PubMedCrossRefPubMedCentralGoogle Scholar
  161. Wong BC, Chau CK, Ao FK et al (2019) Differential associations of depression-related phenotypes with cardiometabolic risks: polygenic analyses and exploring shared genetic variants and pathways. Depress Anxiety 36(4):330–344PubMedCrossRefPubMedCentralGoogle Scholar
  162. Woods SW (2000) The economic burden of bipolar disease. J Clin Psychiatry 61(Supp 13):38–41PubMedPubMedCentralGoogle Scholar
  163. Wray NR, Ripke S, Mattheisen M et al (2018) Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression. Nat Genet 50(5):668–681PubMedPubMedCentralCrossRefGoogle Scholar
  164. Wright KP, Lowry CA, Lebourgeois MK (2012) Circadian and wakefulness-sleep modulation of cognition in humans. Front Mol Neurosci 5:50PubMedPubMedCentralGoogle Scholar
  165. Xiao X, Wang L, Wang C et al (2017) Common variants at 2q11.2, 8q21.3, and 11q13.2 are associated with major mood disorders. Transl Psychiatry 7(12):1273Google Scholar
  166. Xiao X, Zheng F, Chang H et al (2018) The gene encoding protocadherin 9 (PCDH9), a novel risk factor for major depressive disorder. Neuropsychopharmacol: Off Publ Am Coll Neuropsychopharmacol 43(5):1128–1137CrossRefGoogle Scholar
  167. Yu C, Baune BT, Wong ML et al (2017a) Investigation of copy number variation in subjects with major depression based on whole-genome sequencing data. J Affect Disord 220:38–42PubMedCrossRefPubMedCentralGoogle Scholar
  168. Yu C, Baune BT, Licinio J et al (2017b) Whole-genome single nucleotide variant distribution on genomic regions and its relationship to major depression. Psychiatry Res 252:75–79PubMedPubMedCentralCrossRefGoogle Scholar
  169. Yu C, Arcos-Burgos M, Licinio J et al (2017c) A latent genetic subtype of major depression identified by whole-exome genotyping data in a mexican-american cohort. Transl Psychiatry 7(5):e1134PubMedPubMedCentralCrossRefGoogle Scholar
  170. Yu C, Arcos-Burgos M, Baune BT et al (2018a) Low-frequency and rare variants may contribute to elucidate the genetics of major depressive disorder. Transl Psychiatry 8(1):70PubMedPubMedCentralCrossRefGoogle Scholar
  171. Yu C, Baune BT, Wong ML et al (2018b) Investigation of short tandem repeats in major depression using whole-genome sequencing data. J Affect Disord 232:305–309PubMedCrossRefPubMedCentralGoogle Scholar
  172. Zant JC et al (2011) Increases in extracellular serotonin and dopamine metabolite levels in the basal forebrain during sleep deprivation. Brain Res 1399:40–48PubMedCrossRefPubMedCentralGoogle Scholar
  173. Zarate CA Jr et al (2006) A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63(8):856–864PubMedCrossRefPubMedCentralGoogle Scholar
  174. Zeng Y, Navarro P, Fernandez-Pujals AM et al (2017) A combined pathway and regional heritability analysis indicates NETRIN1 pathway is associated with major depressive disorder. Biol Psychiat 81(4):336–346PubMedCrossRefPubMedCentralGoogle Scholar
  175. Zeni CP et al (2016) BDNF Val66Met polymorphism and peripheral protein levels in pediatric bipolar disorder and attention-deficit/hyperactivity disorder. Acta Psychiatr Scand 134(3):268–274PubMedCrossRefGoogle Scholar
  176. Zhang EE, Kay SA (2010) Clocks not winding down: unravelling circadian networks. Nat Rev Mol Cell Biol 11(11):764–776PubMedCrossRefGoogle Scholar
  177. Zhang C, Wu Z, Zhao G et al (2016) Identification of IL6 as a susceptibility gene for major depressive disorder. Sci Rep 6:31264Google Scholar
  178. Zhao L et al (2015) Association study of dopamine receptor genes polymorphism with cognitive functions in bipolar I disorder patients. J Affect Disord 170:85–90PubMedCrossRefGoogle Scholar
  179. Zhou X, Barrett TB, Kelsoe JR (2008) Promoter variant in the GRK3 gene associated with bipolar disorder alters gene expression. Biol Psychiatry 64(2):104–110PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  1. 1.Division of Mood Disorders, Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghaiChina
  2. 2.Department of PsychiatryShenzhen Kangning HospitalShenzhenChina

Personalised recommendations